Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Biotechnology is a broad discipline in which ... Evidence from rhesus macaques and an individual with advanced heart failure suggests that structural and functional augmentation of the failing ...

"Building long-term strengths and becoming a high-tech seed service company led by biotechnology is Origin's first consideration," stated Mr. Yan. "We are committed to developing into an ...

Advanced Therapies Week 2025—a conference focused on the latest innovations in cell and gene therapies, regenerative medicine ...

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

MAIA Biotechnology, Inc., (NYSE American ... cemiplimab (Libtayo®) in patients with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care therapy regimens.